PMC:7696151 / 111297-112071 2 Projects
Annnotations
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T756 | 0-462 | Sentence | denotes | Gautret et al. (2020) [32] Open-label non-randomized clinical trial36 patients HCQ group -> 600 mg/day HCQ (n = 14); 600 mg/day HCQ +500 mg AZM on day 1 followed by 250 mg/day for 4 days (n = 6)Control group (n = 16)Day 10 On day 6, 70% of HCQ-treated patients were virologically cured comparing to 12.5% in the control groupOn day 6, 100% of HCQ+AZM treated patients are virologically cured comparing to 57.1% in the HCQ group and 12.5% in the control group. |
| T757 | 464-603 | Sentence | denotes | Gastrointestinal side effects in one patient of HCQ group.One patient of the HCQ group died on day 3 although he was PCR-negative on day 2. |
| T758 | 605-774 | Sentence | denotes | Small sample-size.Dropout of six patients from HCQ group.Data available up to 6 days despite the planned 10 days.Details about control group treatment are not available. |